Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors

Clinical trial NCT02034708 · COMPLETED

Trial details

NCT number: NCT02034708
Sponsor: Guerbet
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Primary Brain Tumor

Start date: 2014-06-01
Primary completion: 2015-09-01
Enrollment: 279

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.